Chicago, Jan. 15, 2026 (GLOBE NEWSWIRE) -- The global left atrial appendage closure devices market was valued at 1.98 billion in 2024 and is expected to reach US$ 9.40 billion by 2033, growing at a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Rates of patency and device-related thrombus were ...

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...

Approximately 10.5 million Americans have atrial fibrillation (AFib), a condition that causes an irregular, often too fast, ...

Please provide your email address to receive an email when new articles are posted on . A next-generation LAA closure device gained FDA approval to reduce risk for stroke in patients non-valvular AF.

First and only steerable delivery system designed to help seal the left atrial appendage (LAA) in people with atrial fibrillation who are at an increased risk of stroke Now available in the U.S., ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

PHOENIX -- A novel transcatheter device that twists the left atrial appendage (LAA) closed from the inside appeared safe in first-in-human results. Among 15 atrial fibrillation patients who received ...

CHICAGO -- For patients at high risk of stroke who underwent catheter-based atrial fibrillation ablation, left atrial appendage closure led to less bleeding compared with oral anticoagulation, the ...